Vanda Pharmaceuticals sues U.S. government over drug trade secrets

By Blake Brittain (Reuters) – Vanda Pharmaceuticals Inc has sued the federal government in Washington, D.C., federal court over accusations that the U.S. Food and Drug Administration passed trade secrets about its schizophrenia drug Fanapt and sleep-disorder medication Hetlioz to generic competitors. In a complaint made public Tuesday, Vanda said the agency disclosed confidential details…

Read More